Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
Seymour Akshun
This is an important issue and obviously everyone should get the best treatment available. Clinicains need to be able to prescribe the most appropriate treatment. But from what I've seen the side effect profile of Harvoni is not much different to Viekira Pak, especially for people with mild-moderate liver damage. It will be interesting to see what happens in Australia where insurance companies are not involved.
November 3, 2015